Ursprung des Netzwerks ersten Grades von Chris Kiefer
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
15
| Subsidiary | Pharmaceuticals: Major | 15 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Chris Kiefer
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
| EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| INVIVYD, INC. | Biotechnology | Corporate Officer/Principal | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
| University of London | College/University | Doctorate Degree | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The McQuade Center for Strategic Research & Development LLC | President | ||
| Clinical Biotechnology Research Institute | Director/Board Member | ||
| COMPASS PATHWAYS PLC | Biotechnology | Director/Board Member | |
| MUSC Foundation for Research Development | Director/Board Member | ||
Astex Pharmaceuticals Ltd.
 Astex Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Astex Pharmaceuticals Ltd. is a British company that provides drug development services. The company is based in Cambridge, UK. | Pharmaceuticals: Major | Director/Board Member | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Undergraduate Degree | |
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded in March 1991 and is headquartered in Pleasanton, CA. | Pharmaceuticals: Major | Director/Board Member | |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Director/Board Member | |
| The University of North Carolina at Chapel Hill | College/University | Doctorate Degree | |
| Davidson College | College/University | Undergraduate Degree | |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Concordia University | College/University | Undergraduate Degree | |
| Cardiff University School of Medicine | College/University | Doctorate Degree | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Director/Board Member | |
| Emh Consulting Group, Inc. | President | ||
| The Johns Hopkins University | College/University | Undergraduate Degree | |
| Bristol-Myers Squibb Pharma Co. | Corporate Officer/Principal | ||
| Boys & Girls Clubs of New Jersey | Director/Board Member | ||
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| SYNEOS HEALTH, INC. | Biotechnology | Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Amherst College | College/University | Undergraduate Degree | |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| University of Maryland School of Medicine | College/University | Doctorate Degree | |
Cempra Pharmaceuticals, Inc.
 Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Hemab Therapeutics ApS
 Hemab Therapeutics ApS BiotechnologyHealth Technology Hemab Therapeutics ApS is a clinical-stage biotech company based in Copenhagen, Denmark and MA. The Danish company is focused on developing novel prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders. Hemab is progressing a pipeline of monoclonal and bispecific antibody-based therapeutics to transform the treatment paradigm for patients with high unmet need. The company's strategic guidance, Hemab 1-2-5tm, targets the development of 5 independent assets by 2025 to deliver long-awaited innovation for patients with high unmet need blood-clotting disorders like Glanzmann thrombasthenia, Factor VII deficiency, Bernard Soulier syndrome, von Willebrand disease, and other serious disorders. | Biotechnology | Director/Board Member | |
| EPIZYME, INC. | Biotechnology | General Counsel | |
| University of Cardiff | College/University | Undergraduate Degree | |
| Loyola University Maryland, Inc. | College/University | Undergraduate Degree | |
| Georgetown University Law Center | College/University | Graduate Degree | |
| Columbia Business School | College/University | Masters Business Admin | |
Satellite Healthcare, Inc.
 Satellite Healthcare, Inc. Medical/Nursing ServicesHealth Services Satellite Healthcare, Inc. is a non-profit, community benefit organization that provides medical services to patients with chronic kidney disease. The company operates dialysis center and provides training and support for patients performing dialysis at home. It also offers pre-dialysis patient wellness education programs that can help prevent or slow the progression of early stage chronic kidney disease. It was founded by Norman S. Coplon in 1973 and is headquartered in San Jose, CA. | Medical/Nursing Services | Director/Board Member | |
| AKSYS LTD. | Financial Conglomerates | Director/Board Member | |
| KINETA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 41 |
| Vereinigtes Königreich | 7 |
| Kanada | 3 |
| Dänemark | 3 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 16 |
| Finance | 3 |
| Technology Services | 2 |
| Health Services | 2 |
Operativ
| Director/Board Member | 46 |
| Independent Dir/Board Member | 16 |
| Corporate Officer/Principal | 11 |
| Chief Tech/Sci/R&D Officer | 10 |
| Director of Finance/CFO | 9 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Chris Kiefer
- Unternehmensverbindungen
